SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure

Clinical trial NCT06955260 · NOT_YET_RECRUITING

Trial details

NCT number: NCT06955260
Sponsor: Subodh Verma
Status: NOT_YET_RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Congenital Heart Disease

Start date: 2025-05-01
Primary completion: 2027-12-01
Enrollment: 410

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.